
Core Viewpoint - A securities class action lawsuit has been filed against Zynex, Inc. for allegedly misleading investors regarding its revenue practices and product shipments [1][3]. Company Overview - Zynex, Inc. is a medical device company based in Englewood, CO, specializing in electrotherapy devices for pain management and rehabilitation [2]. Lawsuit Details - The lawsuit claims that Zynex shipped products, including electrodes, beyond actual demand, allowing the company to inflate its revenue [3]. - It is alleged that Zynex's practice of filing false claims attracted scrutiny from insurers, including Tricare, which could lead to adverse consequences such as removal from insurer networks and federal penalties [3]. Investor Information - Investors who purchased Zynex securities during the class period (March 13, 2023, to March 11, 2025) have until May 19, 2025, to seek appointment as lead plaintiff [2].